FDA Expected to Lift 2023 Peptide Restrictions
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- The FDA is anticipated to lift its 2023 restriction on peptides, allowing compounding pharmacies to resume sales.
- Peptides were previously removed from the agency's list of products available through compounding pharmacies.
- RFK Jr.'s wishes are being heeded by the FDA's expected reversal regarding peptide sales.
Why it matters: The FDA's reversal will allow compounding pharmacies to continue selling peptides, impacting consumers seeking health and longevity benefits.
